Dr. Victor Moyo has been appointed as the Chief Medical Officer at Onconova Therapeutics, Inc, a US-based clinical-stage Biopharmaceutical Company. Dr. Moyo bri.
Dr. Victor Moyo has been appointed as the Chief Medical Officer at Onconova Therapeutics, Inc, a US-based clinical-stage Biopharmaceutical Company. Dr. Moyo brings with him extensive experience as a physician, researcher, and drug developer in the pharmaceutical industry. He has held various senior leadership positions, overseeing clinical development plans, IND filings, NDA filings, and post-market…
Dr. Victor Moyo has been appointed as the Chief Medical Officer at Onconova Therapeutics, Inc, a US-based clinical-stage Biopharmaceutical Company. Dr. Moyo brings with him extensive experience as a physician, researcher, and drug developer in the pharmaceutical industry. He has held various senior leadership positions, overseeing clinical development plans, IND filings, NDA filings, and post-market…
24.10.2023 - Dr. Victor Moyo named Chief Medical OfficerMeena Arora joins as Vice President Global Medical Affairs and R&D NEWTOWN, Pa., Oct. 24, 2023 (GLOBE NEWSWIRE) - Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”, the “Company”), a clinical-stage . Seite 1
19.10.2023 - Data for Mantle cell lymphoma (MCL) presented in Ireland on Oct. 7, 2023Additional studies support broad potential, especially in cyclin-dependent cancers NEWTOWN, Pa., Oct. 19, 2023 (GLOBE NEWSWIRE) - Onconova Therapeutics, Inc. (NASDAQ: ONTX), . Seite 1